Medifast, Inc. (MED) on Q1 2021 Results - Earnings Call Transcript
Operator: Good day, and welcome to the Medifast First Quarter 2021 Earnings Conference Call. All participants will be in a listen-only mode. After today’s presentation, there will be an opportunity to ask questions. Please note this event is being recorded. I would now like to turn the conference over to Reed Anderson, Investor Relations. Please go ahead.
Reed Anderson: Good afternoon, and welcome to Medifast first quarter 2021 earnings conference call. On the call with me today are Dan Chard, Chairman and Chief Executive Officer; and Jim Maloney, Chief Financial Officer. By now, everyone should have access to the earnings release for the period ended March 31, 2021, that went out this afternoon at approximately 4:05 pm Eastern Time. If you have not received the release, it is available on the Investor Relations portion of Medifast’s website at www.medifastinc.com. This call is being webcast, and a replay will be available on the Company’s website.
Dan Chard: Thank you, Reed, and good afternoon to everyone. Thank you for taking time to be with us today. On the call with me today is Jim Maloney, our Chief Financial Officer. I’m going to provide a brief overview of our first quarter, and then Jim will run through our financial results in more detail. Following our prepared remarks, we will open up the call to take your questions. We are proud to report a strong start to 2021, with revenue growth of 91% to nearly $341 million, reflecting continued momentum in independent OPTAVIA Coach growth as well as solid gains in coach productivity. The number of active earning OPTAVIA Coaches exceeded 52,000 in the first quarter, an increase of 61% over last year and up 19% sequentially. Revenue per active earning OPTAVIA Coach hit a new record of $6,454 in the first quarter, an increase of 21% over last year and up 9% sequentially. The accelerating growth we’re seeing in new coaches and in per coach productivity is a demonstration of the strength and differentiation of our coach-based model. And the residents, of a new field-led coach training approach that is being rolled across all geographies. This new approach better leverages social media and communication technology platforms to engage prospective clients, support new clients and support new coaches. Moving forward, our continued investment in digital tools and in our new fully integrated mobile apps for use in the field will enable deeper connections between coaches and clients while also creating efficiencies that allow OPTAVIA Coaches to support a greater number of clients. We remain confident in our ability to drive long-term sustainable growth and deliver on our mission to offer the world Lifelong Transformation, One Healthy Habit at a Time.
Jim Maloney: Thank you, Dan. Good afternoon, everyone. Revenue in the first quarter of 2021 increased 90.9% to $340.7 million from $178.5 million in the first quarter of 2020, reflecting continued growth in the number of active earning OPTAVIA Coaches and higher per coach productivity, which resulted from more clients participating in our Optimal Weight 5 & 1 plan. We achieved another record quarter of active earning OPTAVIA Coaches ending the quarter with 52,500. This represents 61% growth as compared to 32,600 coaches in the same period last year and an 18.8% increase from the end of the fourth quarter of 2020. Average revenue per earning OPTAVIA Coach for the quarter set a new record at $6,454 compared to $5,333 for the first quarter of 2020. Our previous high was $6,329 in the third quarter of 2020. Increase in the productivity per active earning OPTAVIA Coach for the quarter was driven by an increase in both the number of clients supported by each coach as well as an increase in average client spend. As Dan discussed, the growth we’re seeing in new coaches and in coach productivity is because of the new approach that better leverages field-led coach training with social media and communication technology platforms. During the first quarter, we offered limited incentives and promotions, consistent with the prior year. OPTAVIA branded products represented 88.9% of our consumable units sold in the first quarter, up from 79% in the prior year period. Consistent with business and brand strategy, the Company decided to sunset the Medifast branded product line by the end of the second quarter of 2021. Gross profit for the first quarter of 2021 increased 83.8% to $248.5 million compared to $135.2 million in the prior year period. Gross profit as a percentage of revenue was 73%, down 280 basis points compared to 75.8% in the first quarter of 2020. The decrease in gross profit as a percentage of revenue was due to the acceleration of demand in OPTAVIA branded products that led to the increase in the Company’s use of co-manufacturers and the increased need to provide expedited shipments of our products to keep customer experience at acceptable levels in advance of our fulfillment capacity being fully online. Both of these items increased costs. Additionally, gross profit as a percentage of revenue decreased due to inventory write-offs related to the sunset of Medifast branded product line.
Operator: Our first question comes from Doug Lane with Lane Research. Please go ahead.
Doug Lane: Yes. Hi. Good afternoon, everybody. Dan, I have to say the return to growth here happened a lot quicker than certainly I was anticipating. But, the question is, having seen this kind of growth before at the second half of 2018, it’s really almost hyper growth in my mind. And there were some issues following that period of hyper growth with your infrastructure that I know you’ve managed through and you’ve talked about added capacity. You’ve talked about expanded distribution. But, what can you -- how can you assure us that the growth just isn’t too fast here and that you’ve got the infrastructure and the management wherewithal to manage through it at these kind of rates?
Dan Chard: Yes. Doug, thanks for the question. I think, if you go back two years to 2018, we were in the midst of a lot of investment, which we have continued to make a priority, both on the technology side and for the last several years, also on the supply chain side. So, we’re in a good position to have systems that scale with our growth, in every aspect of our business. So, our technology scales based on the cloud, it’s easily expandable. We have a significant network of co-manufacturers and of 3 PL partnerships. We have partners who help us with our client support and services. And we’ve brought on a significant amount of talent to help us manage as we move forward. So, we believe that we have our operations -- and our operational plan and infrastructure in place and ready to deliver not just for 2021, but well beyond 2021.
Doug Lane: Okay. Fair enough. And you certainly have seen those changes, I have to say. I know you didn’t talk about international much. And given the rapid growth in the U.S., it’s obviously still and probably going to be for a while, a small part of your business, but it’s important, I think, longer term. So, can you just give us an update on Hong Kong and Singapore? And is there any thought of expanding beyond those markets in the foreseeable future?
Dan Chard: Sure. I mean, as you know, and we’ve said this in the past, we don’t break out the numbers by market. So, those numbers we reported include Hong Kong and Singapore. You’re right. They remain less than 10% of our overall revenue base, which we stated as our threshold for when we’ll start reporting those. But, the Asia Pacific markets, meaning those two Hong Kong and Singapore have continued to develop and grow at rates that we think is consistent with what we should expect going forward. And as we continue to refine and add all the capability that we’ve continued to focus on, we’re building an expandable model that will allow us to go into all areas of the world, ultimately, that have the same health challenges that we’re talking about. If you remember, Doug, we opened up a distribution center in Hong Kong to provide better service, and we did that last year as well as opening up call centers in Colombia and in the Philippines. So, those are two great examples of infrastructure that we’re building, not just to support the U.S. growth, to your earlier question, but also to support the long-term growth abroad.
Operator: Our next question comes from Linda Bolton Weiser with D.A. Davidson. Please go ahead.
Linda Bolton Weiser: Hi. So, congratulations on such strong growth. So, I guess, I was curious if you could quantify some of the impacts on gross margin in the quarter, at least the inventory write off. Could you quantify that and maybe the expedited shipping item?
Jim Maloney: Sure. This is Jim. So, the Medifast branded products write-off was approximately 70 basis points in the quarter. And the expedited shipment was about 30 basis points in the quarter. There was -- so the premium shipments were about $1 million and the write-off was approximately $2.5 million.
Linda Bolton Weiser: Okay, great. Thank you. And then, your coach growth is spectacular and you talked about some of the reasons that is, and productivity is really rising again, too. Can you talk about how you think about productivity? I know you always say kind of when you’re modeling it, just assume it stays flat going forward. But, it might be actually taking another spurt of growth. Is there any natural ceiling to productivity per coach, or how do you think about that really long-term in terms of the maximum possibility of productivity?
Dan Chard: Yes. This is Dan, Linda. Thanks for asking the question. I think, the -- we look at the things that we do that we characterize as innovative or innovation in the support of our coaches as things that have -- create upward pressure or upward lift to productivity. So, in the case of this last several quarters, what you can see is a training protocol or a program that’s being initiated across all geographies that leverages technology in some more efficient ways. So, think about that as increasing the number of clients that can be attracted to OPTAVIA by single coach, largely leveraging communication tools and social media platforms, and as well as a training approach that allows each coach to train more effectively and more efficiently new coaches. And that’s using mainly large communication technologies like a Zoom platform, and applying a more efficient way of bringing and training larger number of new coaches. So, those are the two kind of accelerators that you’re seeing in the current -- in the current quarter and in the last say, the last two quarters prior to. In terms of the future, in this quarter, we just launched our first two apps. I’ve been talking about this for quite a while. We launched an app for clients, which primarily gives them the ability to access tools to help them with their healthy eating. So, this is a recipe database and ways to help them deliver on that Lean & Green meal. So, fundamental to learning the habit of healthy eating. So we believe that’s going to help coaches support more clients. And then equally important is what we’re calling our OPTAVIA Connect app, which also launched in the second quarter, and that gives access to metrics and some additional functionality to allow coaches to support more clients by making their time more efficient. So, those are some kind of future-looking kind of upward supporting productivity tools that we’ve just launched. So again, the rest of our answer is kind of the same. We don’t try to project forward, which is innovation and investment for us. And then, we watch very closely at what’s working and how to improve it. And as we have done that over the last five years, we’ve seen productivity pretty consistently year-over-year increase. And to your point, we’ve now achieved a new high point. And in essence, we’re also launching technologies that have not yet been reflected in the first numbers.
Linda Bolton Weiser: Okay. And then, sort of as we’re kind of progressing through the different phases of the pandemic here, I know that there’s been some belief out there that direct sellers have benefited from people staying at home and having more time to spend on things like coaching other people. But yes, you’ve said that it’s really some of your Company specific drivers. And I guess, seeing this high growth in a point when the pandemic is -- when we’re starting to reopen, kind of proves that a little. Do you have any update in terms of your belief about what’s going on relative to the pandemic in terms of how sustainable this strong coach growth is, even when we get more reopened?
Dan Chard: Yes. I mean, you’ve been following us for -- since we have implemented this coach-centric model and started refocusing the entire Company’s efforts around building and supporting coaches. So, as you know, our growth started well in advance of the pandemic. We grew 66% in 2018, 42% in 2019, and then, the pandemic year 31%. Now, we’re starting off this new year with significant growth. We believe that there hasn’t been a lot of benefit to us from the pandemic. But, what we do see is that the addressable market that we focus on is very significant. It is a $20 billion market and is reflective of the challenges that we’ve been focusing on for the last five years, which is over two-thirds of Americans are either overweight or obese. Most of those have tried dieting and have failed in doing it. And most of those are interested still in having support in creating a health transformation. And what we’re really seeing is a -- is that our coach-centric model is resonating against that very large population. And we’ve done the research to recognize that that same dynamic goes well beyond our country. So, we believe we have many years of opportunity by focusing on that addressable and growing market.
Linda Bolton Weiser: Thanks. And then, I don’t know if you’ve heard or seen, but Beachbody will be coming public through a merger with SPAC here in a couple of months or so. And they’re planning on really investing pretty heavily to drive growth and having actually negative EBITDA in 2021. So, do you feel that as a direct seller of kind of wellness -- and I know it’s a different kind of product and everything, but do you think that could be a threat to you as they really ramp up and try to go for kind of a land grab of market share?
Dan Chard: Yes. I’m not in a great position to comment on other companies. What I can say is that our approach in terms of how we use coaches to be at the center of our model, supported by our products and supported by our community is very unique. And I haven’t seen anyone else who is doing that or who is able to do that. Although I have to say there are plenty of companies out there who are trying to focus on the health and wellness space. So, we’ll continue to do what we do best and continue our investment in our operational infrastructure. And we believe that we are highly differentiated, even among the direct selling community or the direct-to-consumer community in terms of what -- how our coaches work with clients and the fact that our coaches are, for the most part, previously clients. And we’re very -- so we’re a very client-centric or focused company that uses coaches to service those clients. So, I think, there’s a lot of differentiation between us and other companies who are out there trying to focus in the same area. So, we feel confident in our future.
Linda Bolton Weiser: Great. And then, last one for me. Jim, do you have a operating cash flow number and CapEx in the quarter?
Jim Maloney: Sure. So, yes, the operating cash flow is -- so net cash flow provided by operating activities is $65.3 million, and CapEx spend was $4.6 million in the quarter.
Linda Bolton Weiser: And do you have a projection for CapEx for the year, since you said you’re going to spend a little bit more?
Jim Maloney: Yes. At this point, we’re not going to be providing guidance on that other than saying it’s going to be higher as we invest in our fulfillment capabilities and our technology this year. So, it will be higher, but we aren’t going to be providing guidance at this point in time.
Operator: Our next question comes from Sebastian Barbero with Jefferies. Please go ahead.
Sebastian Barbero: Thanks for taking my question. And congrats on the quarter. Dan, my first question, I was wondering if you could comment on the general market dynamics and consumers propensity to lose weight. Obviously, your guide implies ongoing momentum in coming quarters. But, is it your sense that dieting season this year is extending beyond historical standards, or does it manifest that it’s meaningfully outperforming the industry?
Dan Chard: Yes. Thanks, Sebastian, for that question. What we believe is, we’re very focused on being a solution for people who aren’t looking for diets or another diet but are looking for health and wellness. And I think, what we see is that along with January being the traditional diet season, it’s also the time when people start setting goals and many of those are health and wellness goals. So, I’d say that we believe there is a move away from kind of traditional dieting, which is why it’s harder and harder to kind of impact by taking that approach. But, there’s a move towards health and wellness solutions. And so, further, we believe that our approach to offering that health and wellness by teaching healthy habits, the first one being healthy eating, which results in weight loss is alive and very healthy, and in terms of the number of people, if you will, who are looking for that solution. And so, we believe that we stand out in terms of our ability to deliver effectively on that need. So, we’ll never do well with people who are looking for a diet because that’s -- our program goes beyond weight loss, and it’s not about just reducing your eating. It’s about learning a new habit. So, we think that’s -- we think we’re adequately differentiated, which, again, and I think we’ve talked about this in the past, which is why our year from a revenue standpoint doesn’t have Q1 typically as the biggest -- well, Q1 is -- for us, since we’ve adopted this model and focused on coach centric approach, Q1 is not the biggest quarter of the year. Our Q4 is bigger than our Q1. So, this just happens to be when we kick off the year. And so, a strong Q1 has traditionally translated into a strong year for us, which is, I think, reflected in the guidance that Jim kind of called out earlier.
Sebastian Barbero: Got it. And can you talk -- Jim, can you talk to growth trends to Q2? I think in the past two or three earnings call, you mentioned the performance of the first month of the quarter.
Jim Maloney: I’m sorry. Could you repeat that? You broke.
Sebastian Barbero: Sorry, I was wondering if you could comment to growth trends to date in Q2.
Jim Maloney: Yes. I mean, our -- the growth trends in the what I’ll call the month of April, were included in the annual guidance. We’re basically -- when we think it’s very important like -- sort of like what we did with the in-person convention that we’re calling out when we see a large expenditure or something that we think that helps you model, we’ll call those out, but we’re basically going to be staying with full year guidance. What I would say is, the full year guidance reflects our confidence in the future. And the other thing to take a look at is what we did recently with the dividend. And that should provide you some confidence also.
Sebastian Barbero: Okay. And then, Dan, you mentioned you recently launched your coaching client-facing apps. Should we think that there is an opportunity to monetize these?
Dan Chard: Yes. That’s something that we’ve asked ourselves and thought about. It would require us to make some changes on our side. But, the reality is, we think that the opportunity is much more important in terms of getting -- offering this as tool for clients and coaches and stay focused on what we do best from a revenue standpoint, which is largely tied to the food support that we sell. So, yes, we considered it. We have decided at this point that we won’t do it, but again, largely because we want to have these apps available to as many coaches and clients as possible. And we feel like we’ll benefit in long run by having that and maximizing our penetration by not creating any barriers to using this.
Sebastian Barbero: Got it. And last one from me. We have growth comfortably outpacing your long-term target. I was wondering if you could provide some color as to when you could expect this delay in shipping to come down and then for your products to be fully reflected?
Dan Chard: Yes. I mean, that’s part of the reason I gave a little bit of additional color on -- I think you actually said -- asked the question last time, whether the relief in the supply chain would be a straight line or whether it would come earlier. And so, in my comments earlier, the manufacturing capacity for $2 billion, will be achieved in the next two months. And the fulfillment capacity for $2 billion will follow shortly after that. So, we’ve had both, co-manufacturing and additional fulfillment support coming online as recently as this week. And so, we’re seeing that provide greater capacity. But within -- so, we feel confident that we’re heading in the right direction. But, we’re not kind of complete yet, as you’re pointing out. We still have some longer shippings than are typical for us. But we’re doing all the right things to make sure that that’s not a long term issue and that is just a short-term headwind for us.
Operator: This concludes our question-and-answer session. I would like to turn the conference back over to Dan Chard, CEO, for any closing remarks.
Dan Chard: Well, I’d like to conclude by thanking everyone on the call for joining us. As you can see, we have a lot of enthusiasm and belief as we look forward to the rest of 2021. Special thanks to each of our investors for their confidence in both our model and our future, and also a big thanks to our OPTAVIA Coaches who now number above 50,000 across our three geographies. And that’s I don’t think loss on any of them or on you that that’s been a goal of ours for the last 2.5 years to achieve that 50,000 mark. So, thank you, and look forward to reporting our next quarter in a few months here. Thank you.
Operator: The conference has now concluded. Thank you for attending today’s presentation. You may now disconnect.
Related Analysis
Medifast, Inc. (NYSE:MED) Surpasses Market Expectations with Strong Quarterly Earnings
- Medifast, Inc. (NYSE:MED) reported a significant EPS of $0.1029, outperforming the anticipated loss.
- The company's revenue reached approximately $140.2 million, surpassing estimates and indicating robust sales performance.
- Financial health indicators such as a current ratio of 3.11 and a debt-to-equity ratio of 0.09 highlight MED's strong financial position.
Medifast, Inc. (NYSE:MED) is a renowned entity in the health and wellness sector, rivalling firms like Nutrisystem and Weight Watchers. On November 4, 2024, MED unveiled its quarterly earnings, demonstrating a robust performance that surpassed market forecasts.
MED announced earnings per share (EPS) of $0.1029, exceeding the projected loss of $0.28. This accomplishment is particularly noteworthy against the Zacks Consensus Estimate, which had predicted a loss of $0.15 per share. Despite this positive outcome, the EPS represents a decrease from the prior year's $2.12 per share, signaling challenges in sustaining previous profitability levels.
The company also disclosed revenue of approximately $140.2 million, outdoing the anticipated $134.2 million. This revenue achievement underscores MED's capability to exceed sales expectations, as emphasized by Zacks. The price-to-sales ratio of 0.31 implies that investors are paying 31 cents for every dollar of sales, indicating a relatively modest valuation in relation to sales.
MED's financial robustness is further evidenced by a strong current ratio of 3.11, showcasing its ability to meet short-term obligations with current assets. The debt-to-equity ratio of 0.09 reveals a minimal level of debt relative to equity, suggesting a prudent leveraging strategy. Moreover, the enterprise value to sales ratio of 0.16 and enterprise value to operating cash flow ratio of 2.70 offer insights into the company's valuation in comparison to its sales and cash flow.